• No results found

cardiogenic shock

Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art

Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art

... of shock, such as fulminant myocarditis or primary graft failure, have better survival than patients with cardiogenic shock after surgery or acute myocardial infarction [48, ...

10

In hospital mortality of patients with cardiogenic shock after acute myocardial infarction; impact of early revascularization

In hospital mortality of patients with cardiogenic shock after acute myocardial infarction; impact of early revascularization

... Cardiogenic shock is defined as inadequate tissue per- fusion due to primary failure of the heart to function effectively ...[1–3]. Cardiogenic shock is the leading cause of death after acute ...

5

Central extracorporeal life support with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure

Central extracorporeal life support with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure

... The fourth annual INTERMACS report [5] revealed that the proportion of INTERMACS level 1 patients has dropped from 42% in 2006, when the database was im- plemented, to 14% in 2012. Of these patients, only less than 50% ...

9

A study on the effect of biochemical parameters on the outcome and risk stratification of patients with cardiogenic shock following acute myocardial infarction

A study on the effect of biochemical parameters on the outcome and risk stratification of patients with cardiogenic shock following acute myocardial infarction

... This is to certify that this dissertation work titled “A study on the effect of biochemical parameters on the outcome and risk stratification of patients with cardiogenic shock following acute myocardial ...

157

Dobutamine Infusion and Absence of Pulmonary Hypertension Are Associated with Decreased Mortality in a Cohort of 249 Patients with Cardiogenic Shock

Dobutamine Infusion and Absence of Pulmonary Hypertension Are Associated with Decreased Mortality in a Cohort of 249 Patients with Cardiogenic Shock

... studies, cardiogenic shock (CS) mortality is still around 50% ...and cardiogenic shock patients, randomized controlled trials showed similar outcome with infusion of norepinephrine (+/− ...

9

Multidisciplinary management of a large pheochromocytoma presenting with cardiogenic shock: a case report

Multidisciplinary management of a large pheochromocytoma presenting with cardiogenic shock: a case report

... Case presentation: A 38-year-old female patient was admitted to our intensive care unit with hypertension and later cardiogenic shock. Profound systolic dysfunction (left ventricular ejection fraction of ...

6

Blood pressure waveform analysis in cardiogenic shock & acute myocardial infarction

Blood pressure waveform analysis in cardiogenic shock & acute myocardial infarction

... categorizing cardiogenic shock before ...of cardiogenic shock although the relationship with mortality is not very ...the SHOCK- study with the goal of determining cardiogenic ...

70

Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study

Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study

... Furthermore, statistical models applied in this analysis were all adjusted for age, admission year, catecholamine dosages and SAPS II to account for the influence of age, changes in thera- pies during the observation ...

11

Adrenal Insufficiency in  Cardiogenic Shock: Incidence and  Prognostic Implication

Adrenal Insufficiency in Cardiogenic Shock: Incidence and Prognostic Implication

... Introduction: Functional integrity of the hypothalamic pituitary axis is dis- rupted during severe infection or stress. The observed blunted response to corticotropin was interpreted as impaired secretory reserve of the ...

10

Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP SHOCK II) trial

Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP SHOCK II) trial

... in Cardiogenic Shock II trial (IABP- SHOCK II; ...insertion, shock of other cause, or severe concomitant disease with life expectancy <6 ...

9

Sustained Ventricular Tachycardia and Cardiogenic Shock due to Scorpion Envenomation

Sustained Ventricular Tachycardia and Cardiogenic Shock due to Scorpion Envenomation

... There are many other reports of cardiac complications occurring after scorpion stings in children, including acute pulmonary edema and cardiogenic shock [4, 11]. On the other hand, there are few reports of ...

5

Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock

Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock

... A 31-year-old man consulted his local ED for palpita- tions, and headaches associated with chest and abdomi- nal pain. During the preceding year, he had experienced episodic headaches, sweating and palpitations. At ...

9

Incidence of Cardiogenic Shock in Acute Stemi Patients Thrombolysed with Streptokinse

Incidence of Cardiogenic Shock in Acute Stemi Patients Thrombolysed with Streptokinse

... Results: About the complication after receiving thrombolytic therapy 37 % were in cardiogenic shock, 27.5 % land up in CCF, 15% showed arrhythmias. most of cases 85 (42.5 %)ST segment resolution > 50% ...

5

Cardiogenic Shock Complicating MyocardialInfarction: An Updated Review

Cardiogenic Shock Complicating Myocardial Infarction: An Updated Review

... The current review aimed to highlight the update management in patients with ischemic Cardiogenic shock (CS) and its impact on mortality. We reviewed the literature using search engine as MIDLINE, SCOPUS, ...

32

Platelet mitochondrial dysfunction in critically ill patients: comparison between sepsis and cardiogenic shock

Platelet mitochondrial dysfunction in critically ill patients: comparison between sepsis and cardiogenic shock

... septic shock [19] and 16 others with cardiogenic shock [20] within 48 hours from admission to intensive ...with cardiogenic shock, who were expected to have received anti-platelet drugs ...

8

Current concepts in the management of cardiogenic shock

Current concepts in the management of cardiogenic shock

... of shock onset (class I, level of evidence: A) These recommendations were largely driven by the results of the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock ...

10

Clinical evidence of exaggerated inflammation in  patients with a cardiogenic shock complicating ST segment elevation myocardial infarction

Clinical evidence of exaggerated inflammation in patients with a cardiogenic shock complicating ST segment elevation myocardial infarction

... a cardiogenic shock com- plicating first anterior STEMI and 18 demographic matched patients with a non-shock anterior STEMI were ...[5]. Cardiogenic shock was defined as a systolic ...

6

Experts’ recommendations for the management of adult patients with cardiogenic shock

Experts’ recommendations for the management of adult patients with cardiogenic shock

... septic shock, there are no specific international recommendations regarding the management of cardiogenic shock (CS) in critically ill ...of cardiogenic shock in adults, developed with ...

10

Management and outcome of patients supported with Impella 5 0 for refractory cardiogenic shock

Management and outcome of patients supported with Impella 5 0 for refractory cardiogenic shock

... refractory cardiogenic shock was associated with a low day-28 mortality rate and led to myocardial recovery, transplantation or long- term support in 70 % of the implanted ...genic shock, when ...

12

Cardiogenic shock after ST elevation myocardial infarction and IABP-SHOCK II risk score validation in a cohort treated with pharmacoinvasive strategy

Cardiogenic shock after ST elevation myocardial infarction and IABP-SHOCK II risk score validation in a cohort treated with pharmacoinvasive strategy

... of cardiogenic shock in patients with STEMI treated with PhIS, and to be less associated with progression to death when the patient is already in ...

5

Show all 4007 documents...

Related subjects